KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $111.8 million.

  • Quest Diagnostics' Shares Outstanding (Weighted Average) rose 0.45% to $111.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.8 million, marking a year-over-year increase of 0.45%. This contributed to the annual value of $111.6 million for FY2024, which is 0.82% up from last year.
  • Quest Diagnostics' Shares Outstanding (Weighted Average) amounted to $111.8 million in Q3 2025, which was up 0.17% from $111.6 million recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Shares Outstanding (Weighted Average) peaked at $133.5 million during Q1 2021, and registered a low of $110.7 million during Q4 2023.
  • Over the past 3 years, Quest Diagnostics' median Shares Outstanding (Weighted Average) value was $111.6 million (recorded in 2024), while the average stood at $111.5 million.
  • As far as peak fluctuations go, Quest Diagnostics' Shares Outstanding (Weighted Average) fell by 12.06% in 2022, and later climbed by 0.82% in 2024.
  • Quest Diagnostics' Shares Outstanding (Weighted Average) (Quarterly) stood at $119.5 million in 2021, then fell by 6.81% to $111.3 million in 2022, then dropped by 0.55% to $110.7 million in 2023, then rose by 0.82% to $111.6 million in 2024, then increased by 0.45% to $111.8 million in 2025.
  • Its last three reported values are $111.8 million in Q3 2025, $111.6 million for Q2 2025, and $111.6 million during Q1 2025.